T1D Linked to Worse Contrast Sensitivity Function Among Patients Without Retinopathy
What We’re Reading: 6-Week Abortion Ban; Juul to Pay $15M in DC Settlement; Malnutrition Deaths in CA
AJMC® in the Press, April 14, 2023
Biologics May Prevent PsA in Patients With Psoriasis
Certain Exercises Well Tolerated by Patients With Severe Hemophilia
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
What We’re Reading: Restricted Abortion Pill; Cigna Drug Price Transparency; New Parkinson Research
Patient Needs, Antibody Subtype Should Guide Myasthenia Gravis Therapy, Says Dr James Howard
Despite Potential Benefits, Barriers to CAR T-Cell Therapy for DLBCL Persist
Estimating Trends, Quantifying Changes From RSV's Burden on Health Care Systems
Dried Blood Test May Detect HIV, Hepatitis B and C
Trial Results Show Tildrakizumab Is Safe, Effective for Psoriasis Across Ages
Ixazomib Shows PFS Benefit Across Age and Frailty Subgroups in Multiple Myeloma
COPD Associated With Gradual Hearing Loss, Study Finds
Perfluorohexyloctane Reduced Signs and Symptoms of Dry Eye Disease
Review Highlights Gaps in Equity-Focused Cancer Care
How Bariatric Surgery Can Affect Diabetes Complications
What We’re Reading: Xylazine an “Emerging Drug Threat”; White House to Defend Privacy; STIs Reach Record High
Limited English Proficiency, Other Language Preference Associated With Increased COVID-19 Hospitalization Rates
Fecal Microbiota Therapy Potentially Cost-effective at Preventing Recurrent CDI
Association With Autoimmune Diseases Differs Between Epilepsy Types
Many Patients With Hemophilia Experience Functional Declines Over Time
Mental, Physical QOL From CRSwNP Worse vs General Population
Case of Postoperative Heart Attack Demonstrates How MG Can Complicate Cardiac Procedures
What We’re Reading: Autism Rates Rising; Cancer Drugs in Shortage; CMS Promoting Patient Safety, Health Equity
ADAMTS-13 Clearance Major Pathogenic Mechanism in iTTP
Secondary Prevention of MACEs Necessary Following Lobar ICH
New Podcast Announcement!
Higher Rates of Respiratory Support Needed in Patients Admitted With RSV
Study Compares Biologics Omalizumab, Mepolizumab, and Dupilumab for Asthma